Characterization of cell line with dedifferentiated GIST‐like features established from cecal GIST of familial GIST model mice

Author:

Sano Daisuke1,Kihara Takako1,Yuan Jiayin2,Kimura Neinei1,Ohkouchi Mizuka1,Hashikura Yuka1,Ohkubo Shuichi3,Hirota Seiichi1ORCID

Affiliation:

1. Department of Surgical Pathology Hyogo Medical University School of Medicine Nishinomiya Japan

2. Department of Pathology The First People's Hospital of Foshan Foshan Republic of China

3. Discovery and Preclinical Research Division Taiho Pharmaceutical Co. Ltd Tsukuba Japan

Abstract

AbstractApproximately 40 families with multiple gastrointestinal stromal tumors (GISTs) and germline c‐kit gene mutations have been reported. Three knock‐in mouse models have been generated, and all the models showed a cecal GIST. In the present study, we established a cell line derived from cecal GIST in a familial GIST model mouse with KIT‐Asp818Tyr. Since the established cells showed spindle‐shaped morphology with atypical nuclei, and since immunohistochemistry revealed that they were positive for α‐SMA but negative for KIT, CD34 and desmin, the phenotypes of the cells were reminiscent of dedifferentiated GIST‐like ones but not the usual GIST‐like ones. Gene expression analysis showed that the cell line, designated as DeGISTL1 cell, did not express c‐kit gene apparently, but highly expressed HSP90 families and glutaminase 1. Pathway analysis of the cells revealed that metabolic pathway might promote their survival and growth. Pimitespib, a heat shock protein 90α/β inhibitor, and Telaglenastat, a selective glutaminase 1 inhibitor, inhibited proliferation of DeGISTL1 cells and the combination of these showed an additive effect. DeGISTL1 cells might be a good model of dedifferentiated GISTs, and combination of Pimitespib and Telaglenastat could be a possible candidate for treatment strategy for them.

Publisher

Wiley

Subject

General Medicine,Pathology and Forensic Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3